In this project we are going to develop a new assay methodology for the early detection of AIDS through the detection of the p24 protein in blood, which appears a few days after the patient has been infected. Using our technology, we will improve the limit of detection in the recognition of target molecules.

BiOD is the lead partner for the read-out hardware and fully responsible for coordinating the commercial exploitation of the AllerScreening platform.